Development of a technology platform for the discovery of new industrial biocatalysts from marine bacterial diversity.
Development of a new platform technology for efficient, fast and cost-effective antibody generation.
Alpha galactosidase for the Industry
Development of the next-stage production platform for industrial enzymes
Green indoor growth factory for production of high value compounds through GMO plants.
Development of a Bispecific therapeutic antibody for the treatment of metastatic breast cancer
Medicines with strongly enhanced in vivo stability, optimal receptor interaction, and early indication of clinical success.
Dual Affinity Protein (DAP) technology for single-use affinity purification of antibodies
Integrated Bioprocess Development Solutions for Shaken Cultures